Biohaven (BHVN) Current Assets (2021 - 2026)

Biohaven has reported Current Assets for 6 years, with the latest figure at $385.6 million in Q1 2026.

• Quarterly Current Assets rose 0.76% year-over-year to $385.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $385.6 million (up 0.76% YoY) and the FY2025 annual result came in at $368.3 million, down 31.6% from the prior year.
• Current Assets grew to $385.6 million in Q1 2026 per BHVN's latest filing, from $368.3 million in the prior quarter.
• Over five years, Current Assets peaked at $587.0 million in Q4 2022 and troughed at $80.6 million in Q3 2022.
• A 5-year average of $411.6 million and a median of $434.1 million in 2023 frame the typical range for Current Assets.
• The sharpest annual moves came in 2022 and 2024: Current Assets surged 519.01% in 2022, then slumped 35.95% in 2024.
• Over 5 years, Current Assets stood at $587.0 million in 2022, then declined by 24.62% to $442.4 million in 2023, then grew by 21.7% to $538.5 million in 2024, then plunged by 31.6% to $368.3 million in 2025, then grew by 4.7% to $385.6 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $385.6 million, $368.3 million, and $323.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.